Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Klein

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoterLoránd L Kis, Daniel Salamon, Emma K Persson, et al.
International Journal of Cancer|July 13, 2002
SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformationNoémi Nagy, Akihiko Maeda, Kentaro Bandobashi, et al.
Biochemical and Biophysical Research Communications|March 7, 2018
Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cellsDorina Ujvari, Noemi Nagy, Harsha S Madapura, et al.
American Journal of Medical Genetics. Part A|February 22, 2011
CNS imaging is a key diagnostic tool in the evaluation of patients with CFC syndrome: two cases and literature reviewEleftheria Papadopoulou, Stavros Sifakis, Katia Sol-Church, et al.
Molecular Cancer Therapeutics|February 20, 2007
Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cellsLaszlo Markasz, Gyorgy Stuber, Bruno Vanherberghen, et al.
Journal of Virology|February 21, 2012
Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cellsDaniel Salamon, Monika Adori, Dorina Ujvari, et al.
Plos One|August 28, 2014
The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemiaEahsan Rasul, Daniel Salamon, Noemi Nagy, et al.
Genome Research|September 27, 2013
Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalizationKasper D Hansen, Sarven Sabunciyan, Ben Langmead, et al.
Biochemical and Biophysical Research Communications|April 16, 2013
The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulationKalman Szenthe, Anita Koroknai, Ferenc Banati, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Soluble factors produced by activated CD4+ T cells modulate EBV latencyNoémi Nagy, Mónika Adori, Abu Rasul, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoterLoránd L Kis, Daniel Salamon, Emma K Persson, et al.
International Journal of Cancer|July 13, 2002
SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformationNoémi Nagy, Akihiko Maeda, Kentaro Bandobashi, et al.
Biochemical and Biophysical Research Communications|March 7, 2018
Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cellsDorina Ujvari, Noemi Nagy, Harsha S Madapura, et al.
American Journal of Medical Genetics. Part A|February 22, 2011
CNS imaging is a key diagnostic tool in the evaluation of patients with CFC syndrome: two cases and literature reviewEleftheria Papadopoulou, Stavros Sifakis, Katia Sol-Church, et al.
Molecular Cancer Therapeutics|February 20, 2007
Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cellsLaszlo Markasz, Gyorgy Stuber, Bruno Vanherberghen, et al.
Journal of Virology|February 21, 2012
Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cellsDaniel Salamon, Monika Adori, Dorina Ujvari, et al.
Plos One|August 28, 2014
The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemiaEahsan Rasul, Daniel Salamon, Noemi Nagy, et al.
Genome Research|September 27, 2013
Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalizationKasper D Hansen, Sarven Sabunciyan, Ben Langmead, et al.
Biochemical and Biophysical Research Communications|April 16, 2013
The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulationKalman Szenthe, Anita Koroknai, Ferenc Banati, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Soluble factors produced by activated CD4+ T cells modulate EBV latencyNoémi Nagy, Mónika Adori, Abu Rasul, et al.
Pageof 7